Abiopharma

🔍 Bhatt Padmanabh P. (Executive)

Company: SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Report Date: 2025-08-25

Detailed Transactions and Holdings:

• Acquired 1,250 shares of Common Stock (Direct)
  Date: 2025-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,299.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 581 shares of Common Stock at $41.46 per share (Direct)
  Date: 2025-08-25 | Code: F | equity_swap_involved: 0 | shares_owned_after: 13,718.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,250 shares of Performance Share Unit (Derivative)
  Date: 2025-08-25 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F3

Footnotes:

• F1: Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023.
• F2: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
• F3: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.